Neurocysticercosis

被引:7
作者
Takayanagui, Osvaldo M. [1 ]
机构
[1] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Neurosci & Behav, Sao Paulo, Brazil
关键词
cysticercosis; Taenia solium; epilepsy; albendazole; praziquantel; CEREBRAL CYSTICERCOSIS; ALBENDAZOLE; PRAZIQUANTEL; METAANALYSIS; EPILEPSY; TRIAL;
D O I
10.1590/0004-282X20130156
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Cysticercosis is one of the most common parasitic diseases of the nervous system in humans, and constitutes a major public health problem for most of the-developing-world. The clinical manifestations of neurocysticercosis (NCC) largely depend on the the host immune response against the parasite. NCC diagnosis is based upon neuroimaging studies (computerized tomography, magnetic resonance imaging) and antibody/antigen detection in the serum and the cerebrospinal fluid.Anticysticercal therapy has been marked by an intense controversy. Randomized controlled trials evaluating the clinical benefit of treatment have yield conflicting data with some studies indicating a benefit and others failing to show a difference. Prevention strategies must rely on multiple approaches, tailoring each to the special features of the particular endemic area.
引用
收藏
页码:710 / 713
页数:4
相关论文
共 30 条
  • [1] Abba K, 2010, COCHRANE DATABASE SY
  • [2] Capuano Divani M., 2002, Revista do Instituto Adolfo Lutz, V61, P33
  • [3] Capuano DM, 2008, REV BRAS EPIDEMIOL, V11, P687
  • [4] Clinical Manifestations Associated with Neurocysticercosis: A Systematic Review
    Carabin, Helene
    Ndimubanzi, Patrick Cyaga
    Budke, Christine M.
    Hai Nguyen
    Qian, Yingjun
    Cowan, Linda Demetry
    Stoner, Julie Ann
    Rainwater, Elizabeth
    Dickey, Mary
    [J]. PLOS NEGLECTED TROPICAL DISEASES, 2011, 5 (05):
  • [5] Effects of albendazole treatment on neurocysticercosis: a randomised controlled trial
    Carpio, A.
    Kelvin, E. A.
    Bagiella, E.
    Leslie, D.
    Leon, P.
    Andrews, H.
    Hauser, W. A.
    [J]. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (09) : 1050 - 1055
  • [6] IS THE COURSE OF NEUROCYSTICERCOSIS MODIFIED BY TREATMENT WITH ANTIHELMINTHIC AGENTS
    CARPIO, A
    SANTILLAN, F
    LEON, P
    FLORES, C
    HAUSER, WA
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1995, 155 (18) : 1982 - 1988
  • [7] Cysticercosis and epilepsy: A critical review
    Carpio, A
    Escobar, A
    Hauser, WA
    [J]. EPILEPSIA, 1998, 39 (10) : 1025 - 1040
  • [8] Prognosis for seizure recurrence in patients with newly diagnosed neurocysticercosis
    Carpio, A
    Hauser, WA
    [J]. NEUROLOGY, 2002, 59 (11) : 1730 - 1734
  • [9] Proposed diagnostic criteria for neurocysticercosis
    Del Brutto, OH
    Rajshekhar, V
    White, AC
    Tsang, VCW
    Nash, TE
    Takayanagui, OM
    Schantz, PM
    Evans, CAW
    Flisser, A
    Correa, D
    Botero, D
    Allan, JC
    Sarti, E
    Gonzalez, AE
    Gilman, RH
    García, HH
    [J]. NEUROLOGY, 2001, 57 (02) : 177 - 183
  • [10] Meta-analysis:: Cysticidal drugs for neurocysticercosis:: Albendazole and praziquantel
    Del Brutto, Oscar H.
    Roos, Karen L.
    Coffey, Christopher S.
    Garcia, Hector H.
    [J]. ANNALS OF INTERNAL MEDICINE, 2006, 145 (01) : 43 - 51